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A B S T R A C T
Adult-onset Kawasaki disease is a rare condition. Cardiac sarcoidosis is an uncommon cardiomyopathy
which is characterized by progressive cardiac dysfunction, and abnormality on electrocardiography and
morphological aberration of the heart. We report a ﬁrst case of a combination of these rare conditions.
The patient was initially diagnosed with Kawasaki disease based on the coronary artery aneurysms and
a past medical history at the age of 20 years which was typical of Kawasaki disease. Decades later, he
developed progressive cardiac dysfunction and a sudden-onset atrioventricular block. Laboratory and
imaging results revealed severe myocardial damage and inﬂammation which were unexplainable by
coronary artery ischemia. We diagnosed him with cardiac sarcoidosis based on a Japanese guideline to
diagnose cardiac sarcoidosis. A cardiac resynchronization therapy deﬁbrillator was implanted and he
received oral steroid therapy. This rare combination of adult-onset Kawasaki disease and cardiac
sarcoidosis may suggest the causative association of these conditions.
<Learning objective: This is the ﬁrst report of a rare combination of adult-onset Kawasaki disease and
cardiac sarcoidosis. Kawasaki disease is not just a disease of children. Physicians should include
Kawasaki disease in the list of differentials for unknown fever or eruptions. In patients with progressive
heart failure and atrioventricular block, the possibility of cardiac sarcoidosis should be examined using
various imaging modalities even if they had a known cause of cardiac dysfunction.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Kawasaki disease is a type of vasculitis which preferentially
affects children. Kawasaki disease can occur rarely in an adult.
A previous report showed that coronary aneurysm occurs in 5%
of patients with adult-onset Kawasaki disease, and the patients
often suffered from ischemic complications, leading to severe
ischemic cardiomyopathy [1].
Cardiac sarcoidosis, which is a granulomatous disease of
unknown etiology characterized by non-caseating granulomas in
involved organs, is also rare and difﬁcult to diagnose because of its
various clinical courses. In fact, only 40–50% of patients with
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ﬁndings of cardiac sarcoidosis are progressive ventricular dys-
function and arrhythmia, including mainly atrioventricular block.
In the current report, we present an extremely rare combination
of adult-onset Kawasaki disease and cardiac sarcoidosis. This
case tells us one should suspect cardiac sarcoidosis in case of
progressive cardiac dysfunction and atrioventricular block even
in the patients with a known cause of cardiac dysfunction.
Case report
A 58-year-old man with a following past medical history came
to the emergency room with dyspnea worsening over the previous
4 days.
At the age of 20 years, he suffered from a high fever sustained
for 18 days, polymorphous rash, cervical lymphadenopathy,
strawberry tongue, and desquamation of the hands. He was
treated with some intravenous antibiotics as for a bacterial
infectious disease, but antibiotics were not effective. About half as reserved.
Fig. 1.
(A) Coronary angiography shows coronary artery aneurysm at left anterior descending artery #6. (B) Cardiac magnetic resonance imaging with gadolinium
transmural and patchy-delayed enhancement in diffuse left ventricle myocardium.
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48 years, he was diagnosed with Kawasaki disease based on
his past medical history at the age of 20 years and coronary
angiography (CAG) showing coronary artery aneurysm with severe
calciﬁcation on the proximal portion of the left anterior descending
artery (Fig. 1A). At the age of 55 years, he was found to have
complete right bundle branch block and ﬁrst-degree atrioventric-
ular block on an electrocardiogram (ECG) tracing, but his left
ventricular function was preserved at that time [left ventricular
ejection fraction (LVEF): 57%]. The next year, he developed heart
failure with left ventricular dysfunction (left ventricular diastolic
dimension/systolic dimension: 61/47 mm, LVEF: 36%, CAG: #1
100%, #6 aneurysm, #7 75%) and severe mitral regurgitation. He
underwent coronary bypass graft surgery (a graft using left
internal thoracic artery to left anterior descending artery;
sequential grafts using radial artery to ﬁrst diagonal branch and
#4 posterior descending artery), mitral valve repair, and tricuspid
annuloplasty. Despite successful surgical procedure, left ventricu-
lar function did not improve except for some decrease in the left
ventricular diastolic dimension (diastolic dimension/systolic
dimension: 56/47 mm, LVEF: 30%).
Six months after the cardiac operation, he developed dyspnea.
On admission, inspiratory rales were heard at both lungs with
oxygen saturations of 90% on room air. There were a protodiastolic
gallop and grade 2 systolic murmur in the 4th left intercostal space.
He was diagnosed with acute decompensated heart failure [New
York Heart Association (NYHA) class IV] in the emergency room,and was immediately treated with oxygen and intravenous
diuretics. Blood sample investigations revealed that the serum
level of B-type natriuretic peptide was 1284 pg/mL (normal:
<18.4 pg/mL), and troponin T 0.044 ng/mL (normal: <0.014 ng/
mL). ECGs showed a tri-fascicular block (left axis deviation, ﬁrst-
degree atrioventricular block, and complete right bundle branch
block), and wide QRS duration (170 ms). A monitor ECG revealed
non-sustained ventricular tachycardia. A transthoracic echocar-
diogram showed severely reduced left ventricular function (LVEF:
17%) and abnormal septal wall thinning (wall thickness <6 mm).
CAG proved patency of bypass graft. Dyspnea improved 3 days
after admission. However, he suffered from paroxysmal dyspnea,
and an ECG monitor tracing showed an advanced atrioventricular
block at 12th day after hospitalization. He received a transvenous
temporary pacemaker.
The serum level of angiotensin-converting enzyme was 31.3
U/L (normal: 7.7–29.4 U/L). Tuberculin test turned negative, and
there was no obvious sign of uveitis. Computed tomography
showed bilateral hilar lymphadenopathy. A cardiac magnetic
resonance imaging showed a broad damage of the cardiac tissue,
which did not follow the coronary artery distribution (Fig. 1B).
67Gallium scintigraphy and ﬂuorodeoxyglucose (FDG)-positron
emission tomography (PET) revealed broad inﬂammation of the
cardiac tissue (Fig. 2A and B). FDG-PET also showed bilateral hilar
lymphadenopathy (Fig. 2C). He underwent a right ventricular
endomyocardial biopsy. The pathological analyses proved ﬁbrotic
changes in myocardium, but no non-caseating epithelioid cell
Fig. 2.
(A) 67Gallium scintigraphy reveals intense myocardial uptake of gallium all around myocardium without apex and basal-lateral wall. (B and C)
Fluorodeoxyglucose-positron emission tomography was positive in myocardium especially basal-septal and anterior wall [standardized uptake value
(SUV)max7.2] (B), and in bilateral hilar lymphadenopathy (arrow) (SUVmax6.8) (C).
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furosemide 20 mg, omeprazole 15 mg, nicorandil 15 mg, and
rosuvastatin 2.5 mg.
Past history was suggestive of ischemic cardiomyopathy due to
Kawasaki disease. However, the distribution of myocardial damage
did not match the coronary artery distribution. Endomyocardial
biopsy ﬁndings did not suggest other cardiomyopathy and
myocarditis. We ﬁnally diagnosed him as having cardiac sarcoido-
sis complicated with Kawasaki disease.
A cardiac resynchronization therapy deﬁbrillator was
implanted, and he received the standard medical therapy including
an oral b-blocker. He also received an oral steroid therapy (30 mg/
day) in order to inhibit the progressive impairment of cardiac
function. The patient was in NYHA class II and the serum level
of B-type natriuretic peptide was decreased to 286 pg/ml. There
were no advanced atrioventricular block and exacerbation of
cardiac function (LVEF: 24%) after treatment with steroid.
Discussion
This is the ﬁrst report of a combination of adult-onset Kawasaki
disease and cardiac sarcoidosis. Because both the conditions are
relatively rare, it is warranted to carefully discuss the diagnoses
of them.
Kawasaki disease is a childhood vasculitis especially affecting
the coronary artery. Over 90% of cases occur in young children and
infants. Adult-onset Kawasaki disease has been rarely reported,
most cases occur between the age of 18 and 30 years [3]. In the
current case, the patient presented symptoms typical of Kawasaki
disease at the age of 20 years: (1) fever >14 days, (2)
polymorphous rash, (3) cervical lymphadenopathy, (4) oral
changes including injected lips and strawberry tongue, (5)
extremity changes starting with edema, then progressing to
desquamation of the hands starting periungually. Despite typical
symptoms, the correct diagnosis was not made at that time. There
are several clinical differences between pediatric and adult cases of
Kawasaki disease. Coronary artery aneurysm formation wasreported in about 20% of pediatric cases, but only 5% of adult
cases [1]. However, like a pediatric case, coronary angiography and
treatment for cardiac ischemia are important to avoid life-
threatening events caused by cardiac ischemia in adult cases.
The prevalence of sarcoidosis is 10–40/100,000 persons in the
USA and Europe. However, there are some regional differences in
prevalence. A previous report showed that clinically evident
cardiac involvement sarcoidosis is 3–5% [4]. In pathology series,
cardiac involvement in sarcoidosis occurs in 20–79% of patients
[5,6]. In Japanese patients with sarcoidosis, cardiac involvement
may be as high as about 60%, but only about 40% of patients with
cardiac sarcoidosis at autopsy have the correct diagnosis made
during their lifetime [2,5,6]. A deﬁnite diagnosis of cardiac
sarcoidosis is made by endomyocardial biopsy. However, the
sensitivity of endmyocardial biopsy for non-caseating granulomas
is usually less than 20%, because of its patchy myocardial
involvement [7]. On account of its low sensitivity, cardiac
sarcoidosis has often been diagnosed clinically based on other
clinical ﬁndings, including progressive heart failure, atrioventric-
ular block, biomarkers, and various imaging modalities detecting
cardiac damage. The guideline for diagnosis of sarcoidosis requires
evidence of multiple organs involved for deﬁnite clinical diagnosis
in the absence of non-caseating granulomas from biopsy (Table 1)
[8]. We clinically diagnosed the present case as being cardiac
sarcoidosis based on the various cardiac ﬁndings as well as
bilateral hilar lymphadenopathy, which was strongly suggestive of
lung sarcoidosis. PET and radionuclide scan have been known to be
useful to detect myocardial damage and inﬂammation (Fig. 2).
Recent reports showed that cardiac magnetic resonance imaging
reveals the lesion affected by sarcoidosis. Surprisingly, delayed
hyperenhancement represents myocardium that has been
replaced by the ﬁbrogranulomatous tissue, and it can detect even
the inactive lesion affected by sarcoidosis (Fig. 1B) [9,10].
The etiological association between Kawasaki disease and
sarcoidosis has not been known. In a previous article, Propionibac-
terium acnes has been reported as a potentially common causative
agent of these diseases based on pathological examinations
Table 1 Guidelines for diagnosing cardiac sarcoidosis 2006 (Japan Society of Sarcoidosis and Other Granulomatous Disorders).
Histologic diagnosis group
Endomyocardial biopsy demonstrates non-caseating granuloma in addition to the histologic or clinical diagnosis of extracardiac sarcoidosis.
Clinical diagnosis group
Extracardiac sarcoidosis is diagnosed histologically or clinically and satisﬁes the following conditions (at least 2 of 4 major criteria, or one of 4 major criteria and at
least 2 of 5 minor criteria are satisﬁed) and more than one in six basic diagnostic criteria.
Major criteria
(a) Advanced atrioventricular block.
(b) Basal thinning of intraventricular septum.
(c) Positive cardiac 67Ga uptake.
(d) Depressed ejection fraction of the left ventricle (LVEF < 50%).
Minor criteria
(a) Abnormal ECG ﬁndings: ventricular arrhythmias (VT, multifocal or frequent PVCs), CRBBB, axis deviation, or abnormal Q-wave.
(b) Abnormal echocardiography: regional abnormal wall motion or morphological abnormality (ventricular aneurysm, wall thinning).
(c) Nuclear medicine: perfusion defect detected by 201Tl myocardial scintigraphy or 99Tc myocardial scintigraphy.
(d) Gd-enhanced MRI: delayed enhancement of myocardium.
(e) Endomyocardial biopsy: interstitial ﬁbrosis or monocyte inﬁltration over moderate grade.
Basic criteria
(a) Bilateral hilar lymphoadenopathy.
(b) Elevation of angiotensin-converting enzyme.
(c) Negative of tuberculin test.
(d) Positive 67Ga uptake.
(e) Elevation of CD4/CD8 ratio in bronchoalveolar lavage.
(f) Elevation of serum and urine calcium.
ECG, electrocardiogram; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging; PVC, premature ventricular contraction; CRBBB, complete right bundle
branch block; VT, ventricular tachycardia.
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acnes resided in normally peripheral lung tissue. Thus, the
relationship between Propionibacterium acnes and these diseases
remains undetermined. Further studies are needed to conﬁrm this
hypothesis.
This case represents an unusual association of rare diseases,
adult-onset Kawasaki disease and cardiac sarcoidosis. This case
tells us one should suspect cardiac sarcoidosis in case of
progressive cardiac dysfunction and atrioventricular block even
in the patients with a known cause of cardiac dysfunction.
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